Myriad Genetics

Myriad Genetics

Employees:
2,300
Market Cap:
$1.9 billion
Revenue:
$771.2 million
5 Year Trend:
9.2%
Net Income:
$56.3 million
NASDAQ:
MYGN

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. Wikipedia

Myriad Genetics

Employees:
2,300
Market Cap:
$1.9 billion
Revenue:
$771.2 million
5 Year Trend:
9.2%
Net Income:
$56.3 million
NASDAQ:
MYGN

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. Wikipedia

Aug 22, 10:30 AM

Myriad myRisk Hereditary Cancer test is a 28-gene panel that identifies risk for eight cancers. Learn more about this important test by visiting myriad.com! #hereditarycancer #genetics #genetictesting

Aug 18, 10:56 AM

Great news for patients! Myriads EndoPredict test received positive coverage decisions from Medicare and Anthem. This brings total coverage to over 90% of breast cancer patients. Head over to Myriad.com to learn more. #BreastCancer #PrecisionMedicine #companiondiagnostics

Aug 4, 11:50 AM

In 2017, there will be an estimated 161,360 new cases of prostate cancer. Because decisions matter, click here to learn more about Myriads @prolaristest for #ProstateCancer by heading to myriad.com.

Jul 20, 10:24 AM

Myriad Genetics is trusted by more healthcare providers when decisions matter. Head over to our website at myriad.com to learn more. #Genetics #GeneticTesting